Filtrer vos résultats
- 3
- 3
- 3
- 2
- 1
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
Incidence and Characteristics of Pseudoprogression in IDH-mutant High-Grade Gliomas: A POLA Network Study.Neuro-Oncology, 2023, 25 (3), pp.495-507. ⟨10.1093/neuonc/noac194⟩
Article dans une revue
hal-03753737v1
|
|||
|
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter studyInternational Journal of Cancer, 2023, ⟨10.1002/ijc.34636⟩
Article dans une revue
hal-04154476v1
|
||
|
Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastomaCancer Medicine, 2016, 5 (8), pp.1753-1764. ⟨10.1002/cam4.734⟩
Article dans une revue
hal-03036055v1
|